Seroepidemiology of infectious due to members of the herpesvirus group.
about
Valacyclovir for the prevention of recurrent herpes simplex virus eye disease after excimer laser photokeratectomy.Recurrent genital herpes among women: symptomatic v. asymptomatic viral sheddingPrevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection.Social epidemiology of chickenpox in two British national cohorts.Lymphocyte-derived chemotactic factor synthesis in initial genital herpesvirus infection: correlation with lymphocyte transformation.Cytomegalovirus infection in a volunteer blood donor population.Candidate cytomegalovirus strain for human vaccination.Cytomegalovirus retinitis and the acquired immunodeficiency syndrome--bench to bedside: LXVII Edward Jackson Memorial Lecture.Pediatric human immunodeficiency virus infection.Virus-specific antibodies in sera from patients with genital herpes simplex virus infection.Acquisition of cytomegalovirus infection: an update.Sexually transmitted virusesThe blood donor: detection and magnitude of cytomegalovirus carrier states and the prevalence of cytomegalovirus antibodyThe relationship of immunosuppression to cytomegalovirus infection.Cytomegalovirus infection in children undergoing open-heart surgery.Type specificity of complement-fixing antibody against herpes simplex virus type 2 AG-4 early antigen in patients with asymptomatic infection.Comparison of viral isolation, direct immunofluorescence, and indirect immunoperoxidase techniques for detection of genital herpes simplex virus infection.Longitudinal, serological study of cytomegalovirus infections in nurses and in personnel without patient contact.Comparison of antibody-dependent cellular cytotoxicity and complement-dependent antibody lysis of herpes simplex virus-infected cells as methods of detecting antiviral antibodies in human sera.Murine cytomegalovirus infection and apoptosis in organotypic retinal cultures.How to use... neonatal TORCH testing.Neonatal cytomegalovirus infections due to blood.Measurement of antibodies to varicella-zoster virus in a tropical population by enzyme-linked immunosorbent assay.Herpesvirus hominis infections in renal transplant recipients.Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus type 1 glycoprotein H.Quantitation of antibodies to varicella-zoster virus by immune adherence hemagglutination.Immunoglobulins M and G to varicella-zoster virus measured by solid-phase radioimmunoassay: antibody responses to varicella and herpes zoster infections.Clinical aspects of cytomegalovirus infection in kidney-graft recipients.Open-label study of valacyclovir 1.5 g twice daily for the treatment of uncomplicated herpes zoster in immunocompetent patients 18 years of age or older.Early infectious complications in allogeneic marrow transplant recipients with acute leukemia: effects of prophylactic measures.Antibodies to Epstein-Barr virus and some other herpesviruses in patients with sarcoidosis, pulmonary tuberculosis and erythema nodosum.
P2860
Q30979930-F9F8BFAE-B610-46ED-9CC9-BA8998F875E3Q33655980-4EAEBC99-5D91-44DD-A050-BD6B8B2D48EFQ33687109-0435D398-047D-44C0-B7B7-E15F7E5E3B4BQ33701884-E3F624CE-1DD7-4FC9-9F90-054DCFD2715BQ33908843-618E5CA1-3EBF-4BBB-9B36-01C2FC701556Q34117745-E427DD93-934C-4643-AE39-80ECFEB9C7B7Q34126497-505AD9B7-003A-4EDA-B16D-2A0D2E3A39FAQ34670354-7062940B-76C8-4579-B74F-AFC3D6C84790Q35372072-0D8096A2-9EAF-4F7C-9EE2-E8D881D0FAF2Q36330561-0D670258-7860-4B41-95EE-9F5AC16A5861Q36635110-115366B6-7200-4B51-966C-6C67E13B89D7Q36987962-873B220D-DCA9-4281-9DE4-B726845DF2B4Q36998368-A71832BE-DC01-4761-9664-40A58D66685BQ36998384-2A3E3665-AF32-474E-9A07-CA39F2F8C897Q36998400-723DC98F-C215-4F1F-8788-3E7E91CC691CQ37213893-EB43B713-4160-4366-A53C-8EB46B763407Q37336031-3CA4B383-499D-4362-951C-2937ED78B14DQ37342252-4C0EC1C5-099A-483F-8232-127E51307169Q37352632-430ABCD9-133D-41A9-8439-364E270C71C4Q37661144-20A609B9-D5C0-4613-AA80-182FDA5BEB82Q38087436-08DC6C4D-46A4-4548-87A6-DE31C69D545DQ39499631-B0CBF5C5-8204-403E-92A7-2F64C5FE4831Q39556930-A5A66914-A987-4BE5-ADBB-BFF5064D69D4Q39939574-543C0B26-9865-4A3C-BD47-BE9FA5B2E24CQ40127535-25B033E2-065E-4598-B9C1-16A0510A8F8DQ40129539-D4BD983C-A4C8-4ADE-8DAD-00A53D53C17EQ40230925-BA875E37-A4F6-418B-A7A4-697521D2DEBDQ40907620-6CD135E5-3A20-43C3-8796-54B462C1C2C0Q42621014-91CCF12C-6163-42FD-8A68-42AB76134DB6Q44169013-F9E007A7-C879-44CC-89D2-C722C2C5273DQ45818065-8871E5D5-0908-4F51-84D7-2C2C1A50F1EF
P2860
Seroepidemiology of infectious due to members of the herpesvirus group.
description
1971 nî lūn-bûn
@nan
1971年の論文
@ja
1971年学术文章
@wuu
1971年学术文章
@zh-cn
1971年学术文章
@zh-hans
1971年学术文章
@zh-my
1971年学术文章
@zh-sg
1971年學術文章
@yue
1971年學術文章
@zh
1971年學術文章
@zh-hant
name
Seroepidemiology of infectious due to members of the herpesvirus group.
@en
Seroepidemiology of infectious due to members of the herpesvirus group.
@nl
type
label
Seroepidemiology of infectious due to members of the herpesvirus group.
@en
Seroepidemiology of infectious due to members of the herpesvirus group.
@nl
prefLabel
Seroepidemiology of infectious due to members of the herpesvirus group.
@en
Seroepidemiology of infectious due to members of the herpesvirus group.
@nl
P1476
Seroepidemiology of infectious due to members of the herpesvirus group.
@en
P2093
Alexander ER
Wentworth BB
P304
P356
10.1093/OXFORDJOURNALS.AJE.A121347
P407
P577
1971-11-01T00:00:00Z